Hyderabad Telangana, India

Kanchanapally Tejaswini

This inventor holds 2 USPTO granted patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kanchanapally Tejaswini. Retrieved from https://idiyas.com/inventor/kanchanapally-tejaswini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kanchanapally Tejaswini: Innovator in Anti-Cancer Research

Introduction

Kanchanapally Tejaswini is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of anti-cancer research through his innovative work on nimbolide analogs. With a total of 2 patents to his name, Tejaswini is recognized for his dedication to advancing medical science.

Latest Patents

Tejaswini's latest patents focus on nimbolide analogs as anti-cancer agents. The inventions relate to the preparation of these analogs, which are useful in combating cancer. The general formula I of these nimbolide analogs includes various rings and substituents, such as substituted or unsubstituted aryl, heteroaryl, cycloalkyl, and heterocyclic structures. The compounds are designed to include a range of functional groups, enhancing their potential effectiveness as therapeutic agents.

Career Highlights

Tejaswini is affiliated with the Council of Scientific and Industrial Research, where he conducts his research. His work is characterized by a commitment to developing innovative solutions for complex health challenges. His contributions have been instrumental in the ongoing fight against cancer.

Collaborations

Tejaswini has collaborated with esteemed colleagues, including Srivari Chandrasekhar and Prathama Satyendra Mainkar. These partnerships have fostered a collaborative environment that enhances the research output and innovation in their projects.

Conclusion

Kanchanapally Tejaswini stands out as a dedicated inventor in the field of anti-cancer research. His innovative work on nimbolide analogs showcases his commitment to improving health outcomes through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…